TELES Informationstechnologien AG - Asset Resilience Ratio
TELES Informationstechnologien AG (TLIK) has an Asset Resilience Ratio of 0.37% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read TLIK current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2023)
This chart shows how TELES Informationstechnologien AG's Asset Resilience Ratio has changed over time. See TLIK net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down TELES Informationstechnologien AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of TELES Informationstechnologien AG.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €43.38K | 0.37% |
| Total Liquid Assets | €43.38K | 0.37% |
Asset Resilience Insights
- Limited Liquidity: TELES Informationstechnologien AG maintains only 0.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
TELES Informationstechnologien AG Industry Peers by Asset Resilience Ratio
Compare TELES Informationstechnologien AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
|
Sinopharm Group Co. Ltd
F:X2S |
Medical Distribution | 0.00% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
ShareHope Medicine Co Ltd
TWO:8403 |
Medical Distribution | 3.61% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
Annual Asset Resilience Ratio for TELES Informationstechnologien AG (2008–2023)
The table below shows the annual Asset Resilience Ratio data for TELES Informationstechnologien AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.37% | €43.38K ≈ $50.72K |
€11.81 Million ≈ $13.81 Million |
-6.99pp |
| 2022-12-31 | 7.35% | €130.88K ≈ $153.02K |
€1.78 Million ≈ $2.08 Million |
+5.79pp |
| 2011-12-31 | 1.56% | €149.00K ≈ $174.20K |
€9.53 Million ≈ $11.14 Million |
-3.98pp |
| 2008-12-31 | 5.55% | €1.35 Million ≈ $1.58 Million |
€24.42 Million ≈ $28.55 Million |
-- |
About TELES Informationstechnologien AG
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.